StockWatch
·

Glenmark Life Sciences Ltd

BSE: 543322

Shareholding Trends

Ownership split

PromoterPublicOthers
0%31%62%93%Q2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27

Institutional detail

FII / FPIDII
0%3%6%9%Q2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27

Q1 FY27

Corporate Events

Board MeetingALIVUS
2026
29Oct

Board Meeting

The meeting of the Board of Directors will be held to consid…

BSE Filing ↗
Board MeetingALIVUS
2026
8Sep

Board Meeting

The Fifteenth (15th) Annual General Meeting (‘AGM’) of the C…

BSE Filing ↗
DividendALIVUS
2026
1Sep

₹5 / share

BSE Filing ↗
Board MeetingALIVUS
2026
18Aug

Board Meeting

The Board of Directors approved the share purchase agreement…

BSE Filing ↗
Board MeetingALIVUS
2026
30Jul

Board Meeting

The Board of Directors will consider and approve the Unaudit…

BSE Filing ↗
DividendALIVUS
2025
1Sep

₹5 / share

BSE Filing ↗
DividendALIVUS
2025
15May

₹5 / share

BSE Filing ↗
Board MeetingALIVUS
2024
24Oct

Board Meeting

Consider and approve the Unaudited Financial Results

BSE Filing ↗
Board MeetingALIVUS
2024
25Apr

Board Meeting

Consider and approve Audited Financial Results

BSE Filing ↗
Board MeetingALIVUS
2024
23Jan

Board Meeting

Consider and approve the Unaudited Financial Results for the…

BSE Filing ↗
Board MeetingALIVUS
2023
20Oct

Board Meeting

Consider and approve Unaudited Financial Results for the sec…

BSE Filing ↗
DividendALIVUS
2023
17Oct

₹22.5 / share

BSE Filing ↗
Board MeetingALIVUS
2023
9Oct

Board Meeting

Consideration and approval of interim dividend for the finan…

BSE Filing ↗
DividendALIVUS
2023
6Oct

₹22.5 / share

BSE Filing ↗